
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC-T) presents a mixed outlook among experts, with many pointing to its strong capital position, healthy growth in Asia, and attractive dividend yield as positives. Some analysts highlight a recent dip due to earnings concerns, yet the overall sentiment leans toward the belief that MFC is fundamentally sound, especially with its strategic initiatives in wealth management and the Asian market. However, there is caution about potential market volatility and the necessity for macroeconomic factors to shift positively for the stock to reach new heights. The company is seen as a reliable income stock rather than a growth play, with its valuation being reasonable in comparison to peers, although many believe it may be undervalued relative to its long-term potential.
"The longer the base, the bigger the time in space." Investors were patiently clipping coupons, and now there's been an upside breakout. Anyone who bought recently is in the green, and that's really positive.
His contrarian view is that rates are actually going higher; pause for 6-9 months, but then inflation's coming back. If not interest rate increases, it will at least mean no more cutting. Higher rates are pretty positive tailwinds for insurance companies. So even if you've got a gain, keep holding.
Business doesn't have opportunity to reinvest earnings. Dividend payout good, but would rather high rate of return on capital. Compared to a high quality business like Constellation Software - not as good a business. Company will benefit from lower interest rates, but believes there better options for investors out there. Also not founder led/owned.
It is at its highest level in a year. It has 3 major features: top line growth, margin expansion and dividend growth. It is getting out of long term care which is a catalyst. Growing at 9.3% and trading at 9X it is still cheaper than its group. He considers it better than the banks. Lower rates will help with their charges.
Buy 12 Hold 5 Sell 0
De-risked US business, the weakest unit. He's looking at it, on shopping list, hasn't yet pulled trigger. Re-rated nicely, undemanding multiple, single-digit PE ratio. Yield is ~4%. Pay attention to chart validating fundamental changes, often a leading indicator of changes within. Wouldn't quarrel with investors taking a position.
Shares are near 2007 highs. Good balance sheet and managers. He likes the lifeco business, but he will start divesting MFC. MFC is no longer cheap.